Pila Pharma AB (PILA) - Cash Flow Conversion Efficiency

Latest as of June 2025: -1.644x

Based on the latest financial reports, Pila Pharma AB (PILA) has a cash flow conversion efficiency ratio of -1.644x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.91 Million ≈ $-205.06K USD) by net assets (Skr1.16 Million ≈ $124.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Pila Pharma AB - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Pila Pharma AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PILA total debt and obligations for a breakdown of total debt and financial obligations.

Pila Pharma AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pila Pharma AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Athena Resources Ltd AU:AHN	-0.019x
Thor Energy Plc AU:THR	-0.059x
FAST TRACK GROUP NASDAQ:FTRK	-0.699x
Banaras Beads Limited NSE:BANARBEADS	-0.026x
OCEAN-GEOLOOP AS NK -01 F:FQ4	N/A
Kentima Holding publ AB ST:KENH	0.127x
Curanex Pharmaceuticals Inc Common Stock NASDAQ:CURX	-0.643x
Bio-Gene Technology Ltd AU:BGT	-0.811x

Annual Cash Flow Conversion Efficiency for Pila Pharma AB (2018–2025)

The table below shows the annual cash flow conversion efficiency of Pila Pharma AB from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Pila Pharma AB.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr14.78 Million ≈ $1.59 Million	Skr-9.19 Million ≈ $-988.56K	-0.621x	+58.21%
2024-12-31	Skr5.26 Million ≈ $566.17K	Skr-7.82 Million ≈ $-841.88K	-1.487x	-104.07%
2023-12-31	Skr6.66 Million ≈ $716.87K	Skr-4.85 Million ≈ $-522.37K	-0.729x	+23.61%
2022-12-31	Skr9.53 Million ≈ $1.03 Million	Skr-9.09 Million ≈ $-978.34K	-0.954x	-208.63%
2021-12-31	Skr30.30 Million ≈ $3.26 Million	Skr-9.36 Million ≈ $-1.01 Million	-0.309x	+47.16%
2020-12-31	Skr3.42 Million ≈ $368.07K	Skr-2.00 Million ≈ $-215.30K	-0.585x	+13.15%
2019-12-31	Skr7.46 Million ≈ $802.59K	Skr-5.02 Million ≈ $-540.56K	-0.674x	+4.17%
2018-12-31	Skr6.49 Million ≈ $698.79K	Skr-4.56 Million ≈ $-491.12K	-0.703x	--

About Pila Pharma AB

ST:PILA Sweden Biotechnology

Market Cap

$8.01 Million

Skr74.46 Million SEK

Market Cap Rank

#27395 Global

#607 in Sweden

Share Price

Skr1.63

Change (1 day)

+12.41%

52-Week Range

Skr1.10 - Skr3.79

All Time High

Skr12.40